Main navigation
Search Results
-
Save-the-date - - Berlin, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/dmea-2023 -
ProteinDistillery GmbH - 20/04/2022 Using microorganisms to create a source of sustainable protein
Yeast has been part of the human diet for thousands of years. ProteinDistillery GmbH now wants to revolutionise the environmentally friendly protein suppliers market by introducing brewer's yeast and secure the protein supply of the future.
https://www.biooekonomie-bw.de/en/articles/news/using-microorganisms-create-source-sustainable-protein -
pre-start-up company Wheyfinery - 13/04/2022 Acid whey as a valuable raw material for platform chemicals and more
There is not much you can do with acid whey, which is why several million litres of it are disposed of every year. This is both costly and not sustainable. However, researchers at Tübingen University have shown: acid whey can be used to produce precursors for biofuels, fine chemicals and antimicrobial livestock feed additives. They have set up the pre-start-up company Wheyfinery in an endeavour to make their scalable biorefinery concept…
https://www.biooekonomie-bw.de/en/articles/news/acid-whey-valuable-raw-material-platform-chemicals-and-more -
Press release - 13/04/2022 Emmy Noether funding for research into drug resistance of blood cancer
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is funding a new Emmy Noether junior research group at the DKFZ for six years with a total of around 2 million euros. The scientists and doctors, who are part of the Clinical Cooperation Unit for Pediatric Leukemia at the KiTZ, are using a new procedure to investigate how cancer cells manipulate the formation of proteins to become resistant to cancer drugs.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/emmy-noether-funding-research-drug-resistance-blood-cancer -
Event - Health Data Futures – Launch Event 2022
Online, Registration deadline: Informationsveranstaltunghttps://www.gesundheitsindustrie-bw.de/en/event/health-data-futures-launch-event-2022 -
Press release - 12/04/2022 Technology transfer award for PCR rapid test device for infection diagnostics
Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/technology-transfer-award-pcr-rapid-test-device-infection-diagnostics -
COVIC-19 clinical trial - 07/04/2022 Convalescent plasma for COVID-19 therapy: clinical trial should bring clarity
Does it help to treat COVID-19 sufferers with antibodies from people who have recovered from the disease? It seems an obvious idea and has been tested thousands of times. However, there is not yet enough evidence to prove the clinical efficacy of treating COVID-19 patients with convalescent plasma. The transfusion physician Prof. Dr. Hubert Schrezenmeier from Ulm is planning to carry out a follow-up clinical trial to find the missing evidence.
https://www.gesundheitsindustrie-bw.de/en/article/news/convalescent-plasma-covid-19-therapy-clinical-trial-should-bring-clarity -
Event - - EIT Health Summit 2022
Stockholm (Sweden), Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/eit-health-summit-2022 -
Press release - 06/04/2022 High-tech bridge built with flax
The University of Stuttgart is contributing to innovations for climate protection as part of the EU project "Smart Circular Bridge". An old material is being rediscovered: flax has been with us for thousands of years in the form of clothing, sacks, and robust ship's ropes. Now the plant fibres are experiencing a renaissance and could become the building material of the future.
https://www.biooekonomie-bw.de/en/articles/pm/high-tech-bruecke-mit-flachs-gebaut -
Filament winding technology for sustainable construction - 06/04/2022 Robotic building with natural fibres
One of the greatest challenges in the construction industry is the transition to more environmentally friendly and resource-saving buildings. Researchers at the University of Stuttgart are combining state-of-the-art robotic filament winding technologies with ancient local crops to produce stable and sustainable lightweight structures from flax fibres.
https://www.biooekonomie-bw.de/en/articles/news/robotic-building-natural-fibres -
Press release - 06/04/2022 Giant grass miscanthus: Bioethanol source with negative CO2 balance
European collaborative project led by the University of Hohenheim shows: Combining bioethanol production with carbon storage can effectively reduce CO2.
https://www.biooekonomie-bw.de/en/articles/pm/giant-grass-miscanthus-bioethanol-source-negative-co2-balance -
Funding NextGenMicrofluidics
Funding programme, Funded by: JOSNNEUM RESEARCH Forschungsgesellschaft mbH, sb_search.searchresult.label.programSubmissionDate: 30/09/2023https://www.bio-pro.de/en/service/funding/nextgenmicrofluidics-1 -
Press release - 01/04/2022 FDA approval for targeted radioligand therapy for treatment of metastatic prostate cancer
On March 23, 2022, the U.S. Food and Drug Administration (FDA) granted approval to the first targeted radioligand therapy against metastatic prostate cancer based on a joint patent of the German Cancer Research Center (DKFZ) and the University of Heidelberg. The agent significantly improves the chances of survival for those affected.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/fda-approval-targeted-radioligand-therapy-treatment-metastatic-prostate-cancer -
Press release - 30/03/2022 CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
CureVac N.V. a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that the first participant was dosed in a Phase 1 study of COVID-19 second-generation mRNA vaccine candidate, CV2CoV, developed in collaboration with GSK.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-gsk-start-clinical-development-second-generation-covid-19-vaccine-candidate-cv2cov -
Press release - 29/03/2022 Biocopy presents "ValidaTe" – A novel ultra-fast screening technology
ValidaTe enables characterization of efficacy and safety of T-cell drug candidates in days rather than months. The breakthrough speed and unprecedented density of data processed can give partner companies a competitive advantage. New high-throughput microarray technology for label-free characterization of drug candidate interactions can significantly accelerate development in immune-oncology.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/biocopy-presents-validate-novel-ultra-fast-screening-technology -
Event - - Diagnostics-4-Future Conference 2022
Konstanz, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/diagnostics-4-future-conference-2022 -
Event - 14th Innovation Forum Medical Technology
Tuttlingen, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/14-innovation-forum-medizintechnik -
Press release - 21/03/2022 BMBF funds Heidelberg Junior Research Group for 3D Bioprinting Project
Junior Professor Dr Daniela Duarte Campos has been awarded a substantial grant from the Federal Ministry of Education and Research (BMBF). She and her junior research group are investigating bioprinting for tissue and organ engineering at the Center for Molecular Biology of Heidelberg University and at the “3D Matter Made to Order” Cluster of Excellence, a collaboration between Ruperto Carola and Karlsruhe Institute of Technology (KIT).
https://www.gesundheitsindustrie-bw.de/en/article/press-release/bmbf-funds-heidelberg-junior-research-group-3d-bioprinting-project -
Press release - 18/03/2022 Less fossil oil in CO2-reducing plastics
The "carbonauten minus CO2 factory 1" will start production of 4,000 t of CO2-reducing plastic granules annually at favorable prices in summer 2022.
https://www.biooekonomie-bw.de/en/articles/pm/weniger-erdoel-co2-senkenden-kunststoffen -
Press release - 18/03/2022 Lung Tissue from the Lab
Laboratory studies of lung tissue usually require the removal of large amounts of human or animal tissue. Now scientists from the University of Freiburg’s Faculty of Medicine have succeeded in collaboration with American researchers in generating tiny quantities of lung tissue, so-called organoids, from just a few body cells in the lab.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/lung-tissue-lab -